Hammerer, P., & Hofheinz, R. (2018). PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: The non-interventional QoLiTime study. World journal of urology, 36(3), . https://doi.org/10.1007/s00345-017-2138-x
Chicago-Zitierstil (17. Ausg.)Hammerer, Peter, und Ralf-Dieter Hofheinz. "PSA Response to Cabazitaxel Is Associated with Improved Progression-free Survival in Metastatic Castration-resistant Prostate Cancer: The Non-interventional QoLiTime Study." World Journal of Urology 36, no. 3 (2018). https://doi.org/10.1007/s00345-017-2138-x.
MLA-Zitierstil (9. Ausg.)Hammerer, Peter, und Ralf-Dieter Hofheinz. "PSA Response to Cabazitaxel Is Associated with Improved Progression-free Survival in Metastatic Castration-resistant Prostate Cancer: The Non-interventional QoLiTime Study." World Journal of Urology, vol. 36, no. 3, 2018, https://doi.org/10.1007/s00345-017-2138-x.